Grifols(GRFS)
Grifols, S.A. (Catalan: [ˈɡɾifuls]) is a Spanish multinational pharmaceutical and chemical manufacturer. Principally a producer of blood plasma-based products, a field in which it is the European leader and largest worldwide, the company also supplies devices, instruments, and reagents for clinical testing laboratories.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
Mock data
Subscribe for the real data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Albuked, plasbumin, plasbumin, plasbumin | Albumin human | 1942-10-21 | — | |
| Albutein | Albumin human | 1978-08-15 | — | |
| Baygam, gamastan s/d | Globulin, immune | 1944-01-11 | ||
| Bayhep b, hyperhep b s/d | Human hepatitis b virus immune globulin | 1977-09-23 | ||
| Bayrab,hyperrab | Human rabies virus immune globulin | 1974-06-12 | — | |
| Baytet, hypertet | Human clostridium tetani toxoid immune globulin | 1957-10-17 | ||
| Flebogamma dif (previously flebogammadif) | Human normal immunoglobulin | 2007-07-23 | — | |
| Gamimune | Globulin, immune | 1981-09-11 | ||
| Human albumin grifols | Albumin human | 1995-02-17 | — | |
| Koate, koate-dvi | Antihemophilic factor | 1974-01-24 | — | |
| Plasmanate | Plasma protein fraction (human) | 1958-10-02 |
1
2
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use